Behcet disease research in 2020 spanned topics in diagnosis, pharmacologic management and quality of life. We wrap up the year with 8 new study summaries.
Behçet disease (BD) research published in 2020 included guidelines for management during the COVID-19 pandemic and spanned topics from challenges in (and solutions for) BD pediatric diagnosis to a promising, cost-effective predictor of BD activity.
Following are highlights of 8 new studies, a concise summary now cataloged in the Patient Care Behçet Disease Topic Resource Center. You can visit the TRC by clicking on the link at the end of the slide show.